dc.contributor.author | Ghaderi, A | |
dc.contributor.author | Ahmadi, MRH | |
dc.contributor.author | Hosseini, E | |
dc.contributor.author | Akbari, AAM | |
dc.contributor.author | Feyzi, AAHP | |
dc.contributor.author | Hiradfar, A | |
dc.contributor.author | Hagh, MF | |
dc.date.accessioned | 2018-08-26T09:32:38Z | |
dc.date.available | 2018-08-26T09:32:38Z | |
dc.date.issued | 2016 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/57391 | |
dc.description.abstract | In this study, we have determined the allele frequency of HFE mutations H63D and C282Y in a group of Azerian beta-thalassemia major patients. These two mutations are implicated in hereditary hemochromatosis among Caucasians. In this study, we wanted to outbreak these mutations with the iron status in major beta-thalassemia patients. Sixty Azerian major beta-thalassemias were screening for the C282Y and H63D by digestion of polymerase chain reaction products (PCRP). Serum ferritin level was measured by enzyme-linked immunosorbent assay (ELISA). The allele frequency of H63D mutation was 20آ %. C282Y mutation was not present in our studied patients. No statistically significant difference of serum ferritin level was found between major beta-thalassemia with and without HFE mutations. Our data suggest that H63D mutation is so frequent in Azerian major beta-thalassemia patients than in the general population and that the coinheritance of H63D mutation does not influence the severity of iron overload in these patients. آ© 2015, Springer-Verlag London. | |
dc.language.iso | English | |
dc.relation.ispartof | Comparative Clinical Pathology | |
dc.title | Prevalence of the C282Y and H63D mutations of the HFE hemochromatosis gene in Azerian major ?-thalassemia and iron overload | |
dc.type | Article | |
dc.citation.volume | 25 | |
dc.citation.issue | 1 | |
dc.citation.spage | 151 | |
dc.citation.epage | 154 | |
dc.citation.index | Scopus | |
dc.identifier.DOI | https://doi.org/10.1007/s00580-015-2156-2 | |